β¨ Medicine Distribution Consents
1440 NEW ZEALAND GAZETTE No. 65
Product:
Propofol
Active Ingredient(s):
Propofol 10mg/mL
Dosage Form:
Emulsion for injection
New Zealand Sponsor:
Abbott Laboratories (NZ) Limited
Manufacturer(s):
Abbott Laboratories, Chemical & Agricultural Products Division, North Chicago, Illinois, United States of America
Dated this 7th day of June 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
go4199
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the schedule hereto:
Schedule
Product:
Maxipime
Active Ingredient(s):
Cefepime hydrochloride (monohydrate) 1.202g equivalent to 1.0g cefepime
Dosage Form:
Powder for injection
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturer(s):
Bristol-Myers Squibb Barceloneta Inc, Barceloneta, Puerto Rico
Bristol-Myers Squibb SpA, Sermoneta, Latina, Italy
Product:
Maxipime
Active Ingredient(s):
Cefepime hydrochloride (monohydrate) 2.404g equivalent to 2.0g cefepime
Dosage Form:
Powder for injection
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturer(s):
Bristol-Myers Squibb Barceloneta Inc, Barceloneta, Puerto Rico
Bristol-Myers Squibb SpA, Sermoneta, Latina, Italy
Product:
Maxipime
Active Ingredient(s):
Cefepime hydrochloride (monohydrate) 601mg equivalent to 500mg cefepime
Dosage Form:
Powder for injection
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturer(s):
Bristol-Myers Squibb Barceloneta Inc, Barceloneta, Puerto Rico
Bristol-Myers Squibb SpA, Sermoneta, Latina, Italy
Product:
Temodal
Active Ingredient(s):
Temozolomide 100mg
Dosage Form:
Capsule
New Zealand Sponsor:
Schering-Plough Pty Limited
Manufacturer(s):
Integrated Therapeutics Group Inc Subsidiary Schering-Plough Corporation, Iowa City, Iowa, United States of America
Note: This product has provisional consent.
Product:
Temodal
Active Ingredient(s):
Temozolomide 20mg
Dosage Form:
Capsule
New Zealand Sponsor:
Schering-Plough Pty Limited
Manufacturer(s):
Integrated Therapeutics Group Inc Subsidiary Schering-Plough Corporation, Iowa City, Iowa, United States of America
Note: This product has provisional consent.
Product:
Temodal
Active Ingredient(s):
Temozolomide 250mg
Dosage Form:
Capsule
New Zealand Sponsor:
Schering-Plough Pty Limited
Manufacturer(s):
Integrated Therapeutics Group Inc Subsidiary Schering-Plough Corporation, Iowa City, Iowa, United States of America
Note: This product has provisional consent.
Product:
Temodal
Active Ingredient(s):
Temozolomide 5mg
Dosage Form:
Capsule
New Zealand Sponsor:
Schering-Plough Pty Limited
Manufacturer(s):
Integrated Therapeutics Group Inc Subsidiary Schering-Plough Corporation, Iowa City, Iowa, United States of America
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2000, No 65
Gazette.govt.nz —
NZ Gazette 2000, No 65
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of Propofol
π₯ Health & Social Welfare7 June 2000
Medicine, Distribution, Propofol, Abbott Laboratories
- G. R. Boyd, Chief Advisor, Safety and Regulation
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social WelfareMedicine, Distribution, Maxipime, Temodal, Bristol-Myers Squibb, Schering-Plough